文献速递头颈CT

健康志愿者中不同扫描视野锥形束CT泪道造影的诊断能力与辐射剂量

Diagnostic capability and radiation dose of cone beam CT dacryocystography in different scanning fields of view in healthy volunteers.
PubMed 文献 · Radiol Med · 2020-05-26

本研究为初步研究,15名健康志愿者直立位行锥形束CT泪道造影(CBCT-DCG),按扫描视野分为11×10 cm(A组)、8×8 cm(B组)、5×5.5 cm(C组)三组,由两名有经验的耳鼻喉科医生评估图像质量和诊断有效性并计算有效剂量。结果显示各组图像均能良好显示泪道引流系统及周围结构,图像质量和诊断有效性无差异;与A组相比,B组有效剂量(38.40 μSv)降低38.54%,C组(17.12 μSv)降低72.60%。结论认为缩小视野可大幅降低有效剂量而不影响诊断能力,CBCT-DCG可能是评估泪道引流系统的有效一线影像检查,并可进行功能评估。

要点

  • 缩小CBCT-DCG扫描视野至5×5.5 cm可使有效剂量较11×10 cm降低72.60%,图像质量和诊断有效性无差异。
  • CBCT-DCG可良好显示泪道引流系统及周围结构,并允许对泪道引流进行功能评估。
  • 作者认为CBCT-DCG可能是评估泪道引流系统的有效一线影像检查。

核心结论

  • 通过缩小视野可大幅降低健康志愿者CBCT-DCG的有效剂量而不影响诊断能力。
  • CBCT-DCG可能是评估泪道引流系统的有效一线影像检查,并允许对泪道引流进行功能评估。

研究设计与样本

  • 初步研究,纳入15名健康志愿者,直立位行CBCT-DCG。
  • 前5名使用11×10 cm扫描视野(A组),随后5名使用8×8 cm(B组),最后5名使用5×5.5 cm(C组)。
  • 由两名有经验的耳鼻喉科医生评估图像质量和诊断有效性,并计算比较各组有效剂量。

关键影像表现/征象

  • 所有图像均良好显示泪道引流系统及其周围结构。
  • 不同视野组间图像质量和诊断有效性未见差异。

诊断标准与关键数值

  • A组(11×10 cm视野)有效剂量为参照;B组(8×8 cm视野)有效剂量38.40 μSv,较A组降低38.54%;C组(5×5.5 cm视野)有效剂量17.12 μSv,较A组降低72.60%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Cone beam CT dacryocystography (CBCT-DCG) is a new imaging technique for assessing the lacrimal drainage system (LDS). The purpose of this pilot study is to compare the diagnostic capability and radiation dose of CBCT-DCG in different scanning fields of view (FOV) to evaluate the possibilities of the reduction of radiation dose.

METHODS: Fifteen healthy volunteers underwent CBCT-DCG in an upright position. The first five subjects were scanned using the scanning FOV of 11 × 10 cm (Group A), then 8 × 8 cm (Group B), and the last five subjects 5 × 5.5 cm (Group C). The image quality and diagnostic validity of different groups were evaluated by two experienced otolaryngologists. The effective dose of each group was calculated and compared.

RESULTS: All images showed good delineation of the LDS and its surrounding structures. With regard to the image quality and diagnostic validity, no differences were found among different groups. Compared with Group A, the effective radiation dose for Group B (38.40 μSv) was 38.54% lower and that for Group C (17.12 μSv) was 72.60% lower.

CONCLUSIONS: A substantial reduction of the effective dose for CBCT-DCG in healthy volunteer by decreasing FOV is possible without compromising the diagnostic capability. CBCT-DCG is a potential valid first-line imaging test for the evaluation of LDS, and it permits functional assessment of lacrimal drainage.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Chen Z, Wang J. Diagnostic capability and radiation dose of cone beam CT dacryocystography in different scanning fields of view in healthy volunteers. Radiol Med. 2020. PMID: 32458271. doi:10.1007/s11547-020-01227-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。